Candidate chromosomal regions for genes involved in activation of alternative lengthening of telomeres in human immortal cell lines

Experimental Gerontology

Volumn 38, Issue 6, 2003, Pages 641-651

  Shigeeda, Nobumasa ^a   Uchida, Minoru ^a   Barrett, J Carl ^b,c   Tsutsui, Takeki ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alternative lengthening of telomeres; Human immortal cells; Loss of heterozygosity; Senescence; Telomerase

Indexed keywords

ARTICLE; CELL IMMORTALIZATION; CELL LINE; CELL STRAIN; CONTROLLED STUDY; DNA POLYMORPHISM; GENE ACTIVATION; GENE LOCUS; GENE REPRESSION; HUMAN; HUMAN CELL; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SENESCENCE; TELOMERE; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

EID: 0038241878     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(03)00072-X     Document Type: Article

References (68)

1. Acquati F., Morelli C., Cinquetti R., Bianchi M.G., Porrini D., Varesco L., Gismondi V., Rocchetti R., Talevi S., Possati L., Magnanini C., Tibiletti M.G., Bernasconi B., Daidone M.G., Shridhar V., Smith D.I., Negrini M., Barbanti-Brodano G., Taramelli R. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene. 20:2001;980-988.
2. Bai L., Mihara K., Kondo Y., Honma M., Namba M. Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide. Int. J. Cancer. 53:1993;451-456.
3. Balsara B.R., Bell D.W., Sonoda G., De Rienzo A., du Manoir S., Jhanwar S.C., Testa J.R. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res. 59:1999;450-454.
4. Bandera C.A., Takahashi H., Behbakht K., Liu P.C., LiVolsi V.A., Benjamin I., Morgan M.A., King S.A., Rubin S.C., Boyd J. Deletion mapping of two potential chromosome 14 tumor suppresser gene loci in ovarian carcinoma. Cancer Res. 57:1997;513-515.
5. Banga S.S., Kim S., Hubbard K., Dasgupta T., Jha K.K., Patsalis P., Hauptschein R., Gamberi B., Dalla-Favera R., Kraemer P., Ozer H.L. SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27. Oncogene. 14:1997;313-321.
6. Bertram M.J., Bérubé N.G., Hang-Swanson X., Ran Q., Leung J.K., Bryce S., Spurgers K., Bick R.J., Baldini A., Ning Y., Clark L.J., Parkinson E.K., Barrett J.C., Smith J.R., Pereira-Smith O.M. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell. Biol. 19:1999;1479-1485.
7. Bhattacharya S., Wilson T.M.E., Wojciechowski A.P., Volpe C.P., Scott J. Hypervariable polymorphism in APOC3 gene. Nucl. Acids Res. 19:1991;4799.
8. Bischoff F.Z., Yim S.O., Pathak S., Grant G., Siciliano M.J., Giovanella B.C., Strong L.C., Tainsky M.A. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:1990;7979-7984.
9. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573.
10. Bryan T.M., Englezou A., Gupta J., Bacchetti S., Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
11. Bryan T.M., Englezou A., Dalla-Pozza L., Dunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1997;1271-1274.
12. Cheng J.Q., Lee W.-C., Klein M.A., Cheng G.Z., Jhanwar S.C., Testa J.R. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer. 24:1999;238-242.
13. Dunham M.A., Neumann A.A., Fasching C.L., Reddel R.R. Telomere maintenance by recombination in human cells. Nat. Genet. 26:2000;447-450.
14. El-Naggar A.K., Coombes M.M., Batsakis J.G., Hong W.K., Goepfert H., Kagan J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 16:1998;2983-2987.
15. Epstein C.J., Martin G.M., Schultz A.L., Motulsky A.G. Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine. 45:1966;177-221.
16. Garcia I., Brandt D., Weintraub J., Zhou W., Aapro M. Loss of heterozygosity for the short arm of chromosome 11 (11p15) in human milk epithelial cells immortalized by microinjection of SV40 DNA. Cancer Res. 51:1991;294-300.
17. Gonzalez R., Silva J.M., Dominguez G., Garcia J.M., Martinez G., Vargas J., Provencio M., España P., Bonilla F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br. J. Cancer. 81:1999;503-509.
18. Gupta V.K., Schmidt A.P., Pashia M.E., Sunwoo J.B., Scholnick S.B. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int. J. Cancer. 84:1999;453-457.
19. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Genethon human genetic linkage map. Nat. Genet. 7:1994;246-339.
20. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
21. Herbers J., Schullerus D., Müller H., Kenck G., Chudek J., Weimer J., Bugert P., Kovacs C. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer. 19:1997;29-35.
22. Holland E.A., Beaton S.C., Edwards B.G., Kefford R.F., Mann G.J. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene. 9:1994;1361-1365.
23. Huang H., Qian C., Jenkins R.B., Smith D.I. Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer. 21:1998;152-159.
24. Johnson S.M., Shaw J.A., Walker R.A. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int. J. Cancer. 98:2002;205-209.
25. Karlsson C., Stenman G., Vojta P.J., Bongcàm-Rudloff E., Barrett J.C., Westermark B., Paulsson Y. Escape from senescence in hybrid cell clones involves deletions of two regions located on human chromosome 1q. Cancer Res. 56:1996;241-245.
26. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
27. Kimura M., Furukawa T., Abe T., Yatsuoka T., Youssef E.M., Yokoyama T., Ouyang H., Ohnishi Y., Sunamura M., Kobari M., Matsuno S., Horii A. Identification of two common regions of allelic loss in chromosome arm 12q in pancreatic cancer. Cancer Res. 58:1998;2456-2460.
28. Kohno T., Kawanishi M., Matsuda S., Ichikawa H., Takada M., Ohki M., Yamamoto T., Yokota J. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer. 21:1998;236-243.
29. Kumakura S., Tsutsui T. Loss of heterozygosity on chromosome 6 in immortal human fibroblasts. J. Nippon Dent. Univ. 1:1998;16-19.
30. Kumakura S., Yamamoto A., Yagisawa J., Uchida M., Tsutsui T. Telomere length and telomerase activity in the process of human fibroblast immortalization. Odontology. 90:2002;13-21.
31. Kumata M., Shimizu M., Oshimura M., Uchida M., Tsutsui T. Introduction of cellular senescence in a telomerase negative human immortal fibroblast cell line, LCF-AF.1-3, by human chromosome 6. Int. J. Oncol. 21:2002;851-856.
32. Liang H., Fairman J., Claxton D.F., Nowell P.C., Green E.D., Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc. Natl Acad. Sci. USA. 95:1998;3781-3785.
33. Loughran O., Clark L.J., Bond J., Baker A., Berry I.J., Edington K.G., Ly I.S., Simmons R., Haw R., Black D.M., Newbold R.F., Parkinson E.K. Evidence for inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene. 14:1997;1955-1964.
34. Maris J.M., White P.S., Beltinger C.P., Sulman E.P., Castleberry R.P., Shuster J.J., Look A.T., Brodeur G.M. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res. 55:1995;4664-4669.
35. Mori Y., Matsunaga M., Abe T., Fukushige S., Miura K., Sunamura M., Shiiba K., Sato M., Nukiwa T., Horii A. Chromosome band 16q24 is frequently deleted in human gastric cancer. Br. J. Cancer. 80:1999;556-562.
36. Mullokandov M.R., Kholodilov N.G., Atkin N.B., Burk R.D., Johnson A.B., Klinger H.P. Genomic alterations in cervical carcinoma: loss of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res. 56:1996;197-205.
37. Nakabayashi K., Ogata T., Fujii M., Tahara H., Ide T., Wadhwa R., Kaul S.C., Mitsui Y., Ayusawa D. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235:1997;345-353.
38. 60Co gamma rays. Int. J. Cancer. 35:1985;275-280.
39. Ogino H., Nakabayashi K., Suzuki M., Takahashi E., Fujii M., Suzuki T., Ayusawa D. Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun. 248:1998;223-227.
40. Ohmura H., Tahara H., Suzuki M., Ide T., Shimizu M., Yoshida M.A., Tahara E., Shay J.W., Barrett J.C., Oshimura M. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn. J. Cancer Res. 86:1995;899-904.
41. Peraltra R.C., Casson A.G., Wang R., Keshavjee S., Redston M., Bapat B. Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. Int. J. Cancer. 78:1998;600-605.
42. Perrem K., Bryan T.M., Englezou A., Hackl T., Moy E.L., Reddel R.R. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene. 18:1999;3383-3390.
43. Piao Z., Park C., Park J.-H., Kim H. Allelotype analysis of hepatocellular carcinoma. Int. J. Cancer. 75:1998;29-33.
44. Reddy D.E., Sandhu A.K., DeRiel J.K., Athwal R.S., Kaur G.P. Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells. Oncogene. 18:1999;5100-5107.
45. Ritland S.R., Ganju V., Jenkins R.B. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer. 12:1995;277-282.
46. Steck P.A., Lin H., Langford L.A., Jasser S.A., Koul D., Yung W.K.A., Pershouse M.A. Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes Cancer. 24:1999;135-143.
47. Steenbergen R.D.M., Walboomers J.M.M., Meijer C.J.L.M., van der RaaijHelmer E.M.H., Parker J.N., Chow L.T., Broker T.R., Snijders P.J.F. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene. 13:1996;1249-1257.
48. Sugimoto M., Ide T., Goto M., Furuichi Y. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech. Age Dev. 107:1999;51-60.
49. Takei K., Kohno T., Hamada K., Takita J., Noguchi M., Matsuno Y., Hirohashi S., Uezato H., Yokota J. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res. 58:1998;3700-3705.
50. Takeuchi S., Mori N., Koike M., Slater J., Park S., Miller C.W., Miyoshi I., Koeffler H.P. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res. 56:1996;738-740.
51. Tanaka H., Shimizu M., Horikawa I., Kugoh H., Yokota J., Barrett J.C., Oshimura M. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer. 23:1998;123-133.
52. Tavassoli M., Steingrimsdottir H., Pierce E., Jiang X., Alagoz M., Farzaneh F., Campbell I.G. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br. J. Cancer. 74:1996;115-119.
53. Tokutate Y., Matsumoto T., Watanabe T., Maeda S., Tahara H., Sakamoto S., Niida H., Sugimoto M., Ide T., Furuichi Y. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247:1998;765-772.
54. 1-induced immortalization of cultured skin fibroblasts from a patient with Li-Fraumeni syndrome. Carcinogenesis. 16:1995;25-34.
55. Tsutsui T., Tanaka Y., Barrett J.C. Immortalization of human oral keratinocytes by cotransfection with origin (-) SV40 DNA and c-fos gene. Mol. Biol. Cell. 7:1996;492a.
56. Tsutsui T., Tanaka Y., Matsudo Y., Hasegawa K., Fujino T., Kodama S., Barrett J.C. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation. Mol. Carcinog. 18:1997;7-18.
57. INK4a and pRb inactivation with immortalization of human cells. Carcinogenesis. 23:2002;2111-2117.
58. Uejima H., Shinohara T., Nakayama Y., Kugoh H., Oshimura M. Mapping a novel cellular senescence gene to human chromosome 2q37 by irradiation microcell-mediated chromosome transfer. Mol. Carcinog. 22:1998;34-45.
59. Uzawa K., Suzuki H., Komiya A., Nakanishi H., Ogawa K., Tanzawa H., Sato K. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int. J. Cancer. 67:1996;510-514.
60. Varley J.M., Thorncroft M., McGown G., Appleby J., Kelsey A.M., Tricker K.J., Evans D.G.R., Birch J.M. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene. 14:1997;865-871.
61. Vojta P.J., Futreal A., Annab L.A., Kato H., Pereira-Smith O.M., Barrett J.C. Evidence for two senescence loci on human chromosome 1. Genes Chromosomes Cancer. 16:1996;55-63.
62. Wang X.W., Lin X., Klein C.B., Bhamra R.K., Lee Y.-W., Costa M. A conserved region in human and Chinese hamster X chromosomes can induce cellular senescence of nickel-transformed Chinese hamster cell lines. Carcinogenesis. 13:1992;555-561.
63. Wang P.W., Iannantuoni K., Davis E.M., Espinosa R. III, Stoffel M., Le Beau M.M. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q). Genes Chromosomes Cancer. 21:1998;75-81.
64. Yamamoto A., Kumakura S., Uchida M., Barrett J.C., Tsutsui T. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone. Int. J. Cancer. 2003;. in press.
65. Yaremko M.L., Recant W.M., Westbook C.A. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chromosomes Cancer. 13:1995;186-191.
66. Yeager T.R., Neumann A.A., Englezou A., Huschtscha L.I., Noble J.R., Reddel R.R. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59:1999;4175-4179.
67. Yoo G.H., Xu H.J., Brennan J.A., Westra W., Hruban R.H., Koch W., Benedict W.F., Sidransky D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res. 54:1994;4603-4606.
68. Yu C.-E., Oshima J., Fu Y.-H., Wijsman E.M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J., Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science. 272:1996;258-262.